T. Holbrook

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

A. Look, G. Brodeur, S. Cohn, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study.

A. Cantor, M. Link, A. Goorin, 1995, Medical and pediatric oncology.

The cytosine arabinoside (Ara-C) syndrome.

W. Crist, R. Castleberry, T. Holbrook, 1981, Medical and pediatric oncology.

Cytogenetic and flow cytometric analysis of a pancreatoblastoma.

R. Riley, J. Wiley, V. Joshi, 1995, Cancer genetics and cytogenetics.

Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.

A. Look, M. Valentine, G. Brodeur, 1995, Cancer research.

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.

M. Link, A. Goorin, P. Gieser, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity trials of amsacrine (AMSA) and etoposide +/− azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study

J. Krischer, T. Holbrook, V. Land, 1991, Investigational New Drugs.

Management of localized thoracic neuroblastoma.

W. Crist, R. Castleberry, T. Holbrook, 1979, Medical and pediatric oncology.

Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.

J. Krischer, H. Weinstein, V. Land, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.